KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Adaptive Biotechnologies (ADPT) Equity Ratio (2018 - 2025)

Adaptive Biotechnologies (ADPT) has disclosed Equity Ratio for 8 consecutive years, with 0.43 as the latest value for Q4 2025.

  • Quarterly Equity Ratio rose 13.67% to 0.43 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.43 through Dec 2025, up 13.67% year-over-year, with the annual reading at 0.43 for FY2025, 13.67% up from the prior year.
  • Equity Ratio hit 0.43 in Q4 2025 for Adaptive Biotechnologies, up from 0.42 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.68 in Q1 2021 to a low of 0.36 in Q2 2025.
  • Historically, Equity Ratio has averaged 0.51 across 5 years, with a median of 0.51 in 2023.
  • Biggest five-year swings in Equity Ratio: dropped 20.56% in 2024 and later grew 13.67% in 2025.
  • Year by year, Equity Ratio stood at 0.65 in 2021, then dropped by 17.19% to 0.54 in 2022, then fell by 13.93% to 0.47 in 2023, then decreased by 19.49% to 0.38 in 2024, then increased by 13.67% to 0.43 in 2025.
  • Business Quant data shows Equity Ratio for ADPT at 0.43 in Q4 2025, 0.42 in Q3 2025, and 0.36 in Q2 2025.